1. Home
  2. ALH vs DFTX Comparison

ALH vs DFTX Comparison

Compare ALH & DFTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alliance Laundry Holdings Inc.

ALH

Alliance Laundry Holdings Inc.

HOLD

Current Price

$21.80

Market Cap

5.1B

Sector

Industrials

ML Signal

HOLD

Logo Definium Therapeutics Inc. Common Shares

DFTX

Definium Therapeutics Inc. Common Shares

HOLD

Current Price

$36.43

Market Cap

5.9B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALH
DFTX
Founded
1908
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.9B
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
ALH
DFTX
Price
$21.80
$36.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
8
Target Price
$30.88
★ $38.50
AVG Volume (30 Days)
859.6K
★ 2.0M
Earning Date
05-12-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.62
N/A
Revenue
★ $1,709,237,000.00
N/A
Revenue This Year
$7.42
N/A
Revenue Next Year
$5.88
N/A
P/E Ratio
$34.47
★ N/A
Revenue Growth
★ 13.31
N/A
52 Week Low
$18.64
$14.62
52 Week High
$28.23
$49.70

Technical Indicators

Market Signals
Indicator
ALH
DFTX
Relative Strength Index (RSI) 42.99 38.90
Support Level $21.05 $16.37
Resistance Level $22.39 $44.60
Average True Range (ATR) 0.58 1.87
MACD 0.13 -0.08
Stochastic Oscillator 56.78 6.73

Price Performance

Historical Comparison
ALH
DFTX

About ALH Alliance Laundry Holdings Inc.

Alliance Laundry Holdings Inc is a designer and manufacturer of commercial laundry systems, serving diverse international markets. The company offers premium, durable laundry equipment under brands like Speed Queen, UniMac, Huebsch, Primus, IPSO, and others. It serves commercial laundry needs across healthcare, hotels, laundromats, and residential markets. Revenue is generated through the sale of commercial-grade laundry systems and service parts across two geographic segments, North America and International, and into the three end markets of OPL, Vended, and Commercial In-Home.

About DFTX Definium Therapeutics Inc. Common Shares

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

Share on Social Networks: